bpc-157 injection site subcutaneous Where to inject BPC 157 for low back pain BPC-157 Injectable Peptide for Healing
Description
While BPC-157 does not develop traditional tolerance, cycling remains common practice for several reasons including receptor sensitivity maintenance, cost management, and conservative approach given limited long-term human data
It appears that there are people under 65 that are reporting symptoms after the jabs
At doses of 1 mg or less (the typical usage range), side effect rates were similar to placebo
Will all Parkinsons patients start using PRODUODOPA
